How Neurofeedback Breaks the Cycle of Depressive Rumination
Summary: Major Depressive Disorder (MDD) is a heterogeneous condition: symptoms differ widely between patients, and standard first-line treatments such as selective serotonin…
Topic
Category: Topics
Topics
Neural Signal Predicts Attention and Restores Focus in Children
Summary: Researchers have identified a specific brain signal that reliably appears just before attention lapses in children. Monitoring this neural “attention signature”…
How APOE2 Shields Neurons from DNA Damage and Aging
Summary: Researchers report that the APOE2 form of the apolipoprotein E gene helps preserve neuronal DNA and prevents neurons from entering a…
APOE2 Shields Neurons from DNA Damage and Brain Aging
Summary: Researchers have long noticed that people who carry the APOE2 form of the apolipoprotein E gene tend to live longer and…
Personalized DNA Vaccine Doubles Glioblastoma Survival
Summary: Researchers have developed a personalized DNA cancer vaccine that produced encouraging results in an early-stage clinical trial for glioblastoma, showing safety,…
Blocking a Key Protein Slows Parkinson’s Disease Progression
Summary: Researchers have identified a promising new target to slow the progression of Parkinson’s disease (PD). The study finds that glycoprotein nonmetastatic…
Personalized DNA Vaccine Doubles Survival in Glioblastoma
Summary: Researchers have developed a personalized DNA cancer vaccine that produced encouraging results in an early-stage clinical trial for glioblastoma. The trial…
Inhibiting a Key Protein Slows Parkinson’s Disease Progression
Summary: Researchers have identified a promising target for slowing the progression of Parkinson’s disease (PD). The study shows that the protein GPNMB…
How Jumping Genes Shaped Human Brain Evolution
Summary: New research shows that transposable elements (TEs)—previously labeled “junk” DNA—played a central role in the evolution of the mammalian brain by…
GLP-1 Drugs Reduce Food Noise and Speed Weight Loss
Summary: New evidence from Pennington Biomedical shows that combining obesity medications—specifically GLP-1 receptor agonists—with a digital behavioral weight-management program produces a larger…
Readers are exploring
